U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1998
123
Substance Class Protein
Created
by admin
on Mon Mar 31 18:24:29 GMT 2025
Edited
by admin
on Mon Mar 31 18:24:29 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
OP401G7OJC
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
ETANERCEPT
EMA EPAR   HSDB   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
ETANERCEPT, LICENSE HOLDER UNSPECIFIED
Preferred Name English
1-235-TUMOR NECROSIS FACTOR RECEPTOR (HUMAN) FUSION PROTEIN WITH 236-467-IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN FC FRAGMENT), DIMER
Common Name English
ETANERCEPT [USAN]
Common Name English
ETANERCEPT [MART.]
Common Name English
RHU TNFR:FC
Code English
ETANERCEPT [JAN]
Common Name English
ETANERCEPT [VANDF]
Common Name English
ETANERCEPT [EMA EPAR]
Common Name English
etanercept [INN]
Common Name English
ETANERCEPT [HSDB]
Common Name English
ETANERCEPT [EP MONOGRAPH]
Common Name English
ETANERCEPT [PURPLE BOOK CDER]
Common Name English
RHU-TNFR:FC
Code English
Etanercept [WHO-DD]
Common Name English
TNFR-IMMUNOADHESIN
Code English
ETANERCEPT [MI]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 122999
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
WHO-ATC L04AB01
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
LIVERTOX NBK547838
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
EMA ASSESSMENT REPORTS ENBREL (AUTHORIZED: ARTHRITIS, PSORIATIC)
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
EMA ASSESSMENT REPORTS ENBREL (AUTHORIZED: SPONDYLITIS, ANKYLOSING)
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
EMA ASSESSMENT REPORTS ENBREL (AUTHORIZED: ARTHRITIS, RHEUMATOID)
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
NCI_THESAURUS C574
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
EMA ASSESSMENT REPORTS ENBREL (AUTHORIZED: ARTHRITIS, JUVENILE RHEUMATOID)
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
WHO-VATC QL04AB01
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
NDF-RT N0000175451
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
EMA ASSESSMENT REPORTS BENEPALI (AUTHORIZED ARTHRITIS, JUVENILE RHEUMATOID)
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
FDA ORPHAN DRUG 116198
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
NDF-RT N0000175610
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
Code System Code Type Description
WIKIPEDIA
Etanercept
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
PRIMARY
RXCUI
2103480
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
ALTERNATIVE
USAN
JJ-37
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
PRIMARY
CAS
185243-69-0
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
PRIMARY
FDA UNII
OP401G7OJC
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201572
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
PRIMARY
SMS_ID
100000091457
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
PRIMARY
EVMPD
SUB01984MIG
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
PRIMARY
INN
7783
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
PRIMARY
DRUG BANK
DB00005
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
PRIMARY
DAILYMED
OP401G7OJC
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
PRIMARY
IUPHAR
6789
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
PRIMARY
RXCUI
214555
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
PRIMARY RxNorm
MERCK INDEX
m5037
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
PRIMARY Merck Index
LACTMED
Etanercept
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
PRIMARY
DRUG CENTRAL
4978
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
PRIMARY
NCI_THESAURUS
C2381
Created by admin on Mon Mar 31 18:24:29 GMT 2025 , Edited by admin on Mon Mar 31 18:24:29 GMT 2025
PRIMARY
From To
1_240 2_240
1_246 2_246
1_249 2_249
1_281 1_341
1_387 1_445
2_281 2_341
2_387 2_445
Related Record Type Details
ETANERCEPT (ENBREL)
SUB_CONCEPT->SUBSTANCE
ETANERCEPT-SZZS
SUB_CONCEPT->SUBSTANCE
ETANERCEPT BIOSIMILAR ((YLB-113)
BIOSIMILAR -> PARENT
DWP-422
SUB_CONCEPT->SUBSTANCE
ETANERCEPT BIOSIMILAR ((YLB-113)
SUB_CONCEPT->SUBSTANCE
ETANERCEPT-YKRO
SUB_CONCEPT->SUBSTANCE
CHS-0214
SUB_CONCEPT->SUBSTANCE
ETANERCEPT-SZZS
BIOSIMILAR -> PARENT
TUMOR NECROSIS FACTOR-.ALPHA. HUMAN (PLASMA DERIVED, SOLUBLE FORM)
TARGET -> INHIBITOR
LBEC-0101
SUB_CONCEPT->SUBSTANCE
ENIA-11
SUB_CONCEPT->SUBSTANCE
ETANERCEPT-YKRO
BIOSIMILAR -> PARENT
HD-203
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
ETANERCEPT
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:SEQUENCE(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966